Astera Labs (NASDAQ:ALAB) Shares Up 1.9% – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded up 1.9% during trading on Tuesday. The company traded as high as $366.70 and last traded at $357.84. 2,658,819 shares traded hands during trading, a decline of 49% from the average session volume of 5,216,984 shares. The stock had previously closed at $351.31.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Morgan Stanley upped their target price on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Roth Capital reaffirmed a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Finally, Bank of America lifted their price objective on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Stock Up 1.9%

The business’s fifty day moving average is $306.01 and its 200-day moving average is $276.55. The stock has a market capitalization of $62.08 billion, a PE ratio of 177.15 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In other news, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at $1,237,965.10. This trade represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 591,558 shares of company stock valued at $209,458,976 over the last quarter. 10.40% of the stock is owned by insiders.

Institutional Trading of Astera Labs

Large investors have recently modified their holdings of the business. BlackRock Inc. purchased a new position in Astera Labs in the second quarter valued at about $6,609,581,000. Atreides Management LP raised its position in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares in the last quarter. Van ECK Associates Corp increased its stake in shares of Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after buying an additional 373,545 shares during the last quarter. Finally, Bank of America Corp DE bought a new stake in shares of Astera Labs in the second quarter worth $1,061,791,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.